5. Balance Sheets—Additional Information

As of	March 31, 2016			June 30, 2015
Inventories
Raw materials		$	46,971		$	40,012
Work-in-process			9,276			7,617
Finished goods			112,046			102,157
		$	168,293		$	149,786
Goodwill roll-forward
Balance at beginning of period		$	12,613		$	12,613
MVP acquisition			8,499			—
Balance at end of period		$	21,112		$	12,613

We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $4,049 equity investment are currently idled; we have concluded the investment is not currently impaired, based on expected future operating cash flows and/or disposal value.

As of	March 31, 2016			June 30, 2015
Accrued expenses and other current liabilities
Employee related		$	20,394		$	22,273
Commissions and rebates			3,895			4,148
Insurance related			1,403			1,368
Professional fees			4,041			3,543
Income and other taxes			2,003			817
Deferred consideration on acquisitions			1,250			1,196
Fair value of derivatives			220			1,542
Other			11,913			10,576
		$	45,119		$	45,463

As of	March 31, 2016			June 30, 2015
Accumulated other comprehensive income (loss)
Derivative instruments		$	(220)		$	(1,542)
Foreign currency translation adjustment			(47,503)			(32,723)
Unrecognized net pension gains (losses)			(18,546)			(19,884)
(Provision) benefit for income taxes on derivative instruments			(2,327)			63
(Provision) benefit for incomes taxes on long-term intercompany investments			8,166			4,923
(Provision) benefit for income taxes on pension gains (losses)			(2,803)			(2,437)
		$	(63,233)		$	(51,600)